204 related articles for article (PubMed ID: 15485783)
1. [Application of biotin-avidin system in targeted magnetic resonance imaging].
Liu X; Xu YK; Ye J
Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1130-2. PubMed ID: 15485783
[TBL] [Abstract][Full Text] [Related]
2. Targeted magnetic resonance imaging with intraperitoneal and intravenous streptavidin (SA)-DTPA-Gd: a comparative study in tumor-bearing nude mice.
Ye J; Xu YK; Liu X; Lü GS
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):139-43. PubMed ID: 16503514
[TBL] [Abstract][Full Text] [Related]
3. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of [Gd(Bz-TTDA)]2- as a potential contrast agent in MR imaging of the hepatobiliary system: an animal study.
Hsu JS; Jaw TS; Liu GC; Wang YM; Chen SH; Kuo YT; Jao JC; Li CW; Tsai KB
J Magn Reson Imaging; 2004 Oct; 20(4):632-9. PubMed ID: 15390149
[TBL] [Abstract][Full Text] [Related]
5. Antibody fragments in tumor pretargeting. Evaluation of biotinylated Fab' colocalization with recombinant streptavidin and avidin.
Wilbur DS; Hamlin DK; Vessella RL; Stray JE; Buhler KR; Stayton PS; Klumb LA; Pathare PM; Weerawarna SA
Bioconjug Chem; 1996; 7(6):689-702. PubMed ID: 8950488
[TBL] [Abstract][Full Text] [Related]
6. Activated clearance of a biotinylated macromolecular MRI contrast agent from the blood pool using an avidin chase.
Kobayashi H; Kawamoto S; Star RA; Waldmann TA; Brechbiel MW; Choyke PL
Bioconjug Chem; 2003; 14(5):1044-7. PubMed ID: 13129410
[TBL] [Abstract][Full Text] [Related]
7. Chlorophyll-a analogues conjugated with aminobenzyl-DTPA as potential bifunctional agents for magnetic resonance imaging and photodynamic therapy.
Li G; Slansky A; Dobhal MP; Goswami LN; Graham A; Chen Y; Kanter P; Alberico RA; Spernyak J; Morgan J; Mazurchuk R; Oseroff A; Grossman Z; Pandey RK
Bioconjug Chem; 2005; 16(1):32-42. PubMed ID: 15656573
[TBL] [Abstract][Full Text] [Related]
8. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
[TBL] [Abstract][Full Text] [Related]
9. A new class of Gd-based DO3A-ethylamine-derived targeted contrast agents for MR and optical imaging.
Mishra A; Pfeuffer J; Mishra R; Engelmann J; Mishra AK; Ugurbil K; Logothetis NK
Bioconjug Chem; 2006; 17(3):773-80. PubMed ID: 16704217
[TBL] [Abstract][Full Text] [Related]
10. [Gadolinium-loaded nanoparticle as a novel molecular imaging contrast agent for magnetic resonance imaging].
Liu LZ; Guo GJ; Zeng MS; Lü YC; Liu XW; Cui CY; Wu PH; Li L
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):240-3. PubMed ID: 17425867
[TBL] [Abstract][Full Text] [Related]
11. Tumor pretargeting: role of avidin/streptavidin on monoclonal antibody internalization.
Casalini P; Luison E; Ménard S; Colnaghi MI; Paganelli G; Canevari S
J Nucl Med; 1997 Sep; 38(9):1378-81. PubMed ID: 9293791
[TBL] [Abstract][Full Text] [Related]
12. Investigations of avidin and biotin for imaging applications.
Hnatowich DJ; Virzi F; Rusckowski M
J Nucl Med; 1987 Aug; 28(8):1294-302. PubMed ID: 3612292
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine.
Kiryu S; Inoue Y; Watanabe M; Izawa K; Shimada M; Tojo A; Yoshikawa K; Ohtomo K
Magn Reson Imaging; 2009 Jan; 27(1):101-7. PubMed ID: 18599243
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
[TBL] [Abstract][Full Text] [Related]
15. Single-chain Fv-streptavidin substantially improved therapeutic index in multistep targeting directed at disialoganglioside GD2.
Cheung NK; Modak S; Lin Y; Guo H; Zanzonico P; Chung J; Zuo Y; Sanderson J; Wilbert S; Theodore LJ; Axworthy DB; Larson SM
J Nucl Med; 2004 May; 45(5):867-77. PubMed ID: 15136638
[TBL] [Abstract][Full Text] [Related]
16. MR characterization of mild hyperthermia-induced gadodiamide release from thermosensitive liposomes in solid tumors.
Peller M; Schwerdt A; Hossann M; Reinl HM; Wang T; Sourbron S; Ogris M; Lindner LH
Invest Radiol; 2008 Dec; 43(12):877-92. PubMed ID: 19002060
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance molecular imaging of the HER-2/neu receptor.
Artemov D; Mori N; Ravi R; Bhujwalla ZM
Cancer Res; 2003 Jun; 63(11):2723-7. PubMed ID: 12782573
[TBL] [Abstract][Full Text] [Related]
18. [Preparation of a novel targeted MR contrast agent Gd-DTPA-streptavidin and exploration of its reaction conditions].
Liu X; Xu YK; Huang QL
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):15-7. PubMed ID: 14724085
[TBL] [Abstract][Full Text] [Related]
19. Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma.
Leyendecker JR; Gakhal M; Elsayes KM; McDermott R; Narra VR; Brown JJ
J Comput Assist Tomogr; 2008; 32(2):178-84. PubMed ID: 18379298
[TBL] [Abstract][Full Text] [Related]
20. Targeting of vaccinia virus using biotin-avidin viral coating and biotinylated antibodies.
Purow B; Staveley-O'Carroll K
J Surg Res; 2005 Jan; 123(1):49-54. PubMed ID: 15652950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
